Viewing Study NCT01337518


Ignite Creation Date: 2025-12-25 @ 4:47 AM
Ignite Modification Date: 2025-12-26 @ 3:49 AM
Study NCT ID: NCT01337518
Status: SUSPENDED
Last Update Posted: 2012-12-18
First Post: 2011-04-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer
Sponsor: Enzon Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module